177 results
Page 5 of 9
8-K
EX-4.1
ykbtb 0dh
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-4.2
q130kc8pe2we h3xct
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-10.1
ztk7ckuc
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-5.1
tl43lzkcx
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
j33a q3c403
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-1.1
imio29moc8
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
ey95pkjy
10 Jan 22
Prospectus supplement for primary offering
8:00am
PRE 14A
0di92n4v
22 Nov 21
Preliminary proxy
4:45pm
8-K
EX-1.1
iv7fnyrh6l4
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-5.1
3ospc h9vvlp5ax3g
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-4.1
m3i gzzo1t3v0jv3jneq
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
197lev1gag9xy gk89py
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
accibf0 uartelwr3
7 Oct 21
Prospectus supplement for primary offering
5:24pm